Mesoblast Limited (MEOBF)
| Previous Close | 0.4800 |
| Open | 0.4800 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.4800 - 0.4800 |
| 52 Week Range | 0.4400 - 1.5200 |
| Volume | |
| Avg. Volume | 10,229 |
| Market Cap | 312.218M |
| Beta (5Y Monthly) | 2.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
What Type Of Shareholders Make Up Mesoblast Limited's (ASX:MSB) Share Registry?
The big shareholder groups in Mesoblast Limited ( ASX:MSB ) have power over the company. Institutions will often hold...
- Zacks
BioCardia (BCDA) Gains FDA Nod for ARDS Cell Therapy Study
BioCardia (BCDA) gets FDA approval to start a phase I/II study to evaluate its allogenic stem cell therapy candidate, BCDA-04, in patients with ARDS due to COVID-19.
- Motley Fool
Mesoblast Limited (MESO) Q1 2022 Earnings Call Transcript
Hello, and welcome to the Mesoblast financial results for the period ended December 31, 2021. Before we begin, let me remind you that during today's conference call, the company will be making forward-looking statements that represent the company's intentions, expectations or beliefs concerning future events. In addition, any forward-looking statements represent the company's views only as of the date of this webcast and should not be relied upon as representing the company's views of any subsequent dates.
